Skip Navigation

Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implant

Guidance issued Guidance issued
 
IP Guidance Number: IPG44
 
Summary:

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on this procedure.

Description:

Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implant is a form of permanent contraception that does not involve skin incision. This procedure is usually performed under local anaesthesia and/or intravenous sedation and involves the insertion of a small, flexible titanium microinsert into each of the fallopian tubes. The microinsert is placed in the tube through the cervix using a guidewire and a hysteroscope.

The microinsert induces scar tissue, thereby occluding the fallopian tubes and preventing conception. It is recommended that an additional form of contraception be used for 3 months after the operation. At 3 months an imaging procedure is performed to confirm correct placement of the microinserts and whether occlusion has been achieved.

Arrangements:

Special

Topic Area:

Gynaecology, pregnancy and birth
Surgical procedures

Specialty:

General surgery
Obstetrics and gynaecology

Specialist advice has
been sought from:

Royal College of Obstetricians and Gynaecologists

Royal College of General Practitioners

Date notified to NICE: 14 April 2003
Guidance Publication Date: 25 February 2004
Contact Details:
Project Manager
(for general enquiries or comments)
Ben Doak
ip@nice.org.uk
Technical Lead
(for procedure specific enquiries or comments)
Sally Wortley
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA


Links:

Search NICE guidance


Advanced guidance search

Related guidance

Click the links below to see guidance on similar topics